MediPharm appoints CEO

MediPharm appoints CEO

Bryan Howcroft joined MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids, as chief executive officer and director, effective November 15. Howcroft brings more than 20 years of leadership in multiple industries including medical devices, healthcare imaging, and manufacturing. Most recently, he held the position of chief operational officer and chief financial officer of Southmedic, a company that provides healthcare products, custom manufacturing, and distribution in 60-plus countries.

“As a pharmaceutical company specialized in precision-based cannabinoids, MediPharm Labs was seeking a CEO who could lead the charge on increased sales in the medical and consumer markets. We found that CEO in Bryan, who has the experience and expertise in growing medical industry business coupled with knowledge on effective operational management,” said Chris Taves, chairman of MediPharm. “Bryan is a tenacious leader who believes in a customer-first approach that will be critical for MediPharm to scale our business, and will bring a healthy level of urgency to pursue the many opportunities that lie ahead.”

“I look forward to bringing to MediPharm my successful scaling revenue and business operations and to building long-term competitive advantage,” Howcroft said. “I look at MediPharm’s current business and future potential and see a company that is differentiated in the industry with so much more value than what is attributed to it today. I am excited about the opportunity to re-invigorate investor confidence in MediPharm to support our future growth.”